Simon Kohl: AI Makes Biology Programmable
Latent Labs founder Simon Kohl outlines the shift from structure prediction to generative drug design at CVPR 2026.
1 articles about 'Biology'
Latent Labs founder Simon Kohl outlines the shift from structure prediction to generative drug design at CVPR 2026.